Is a Peer Review required for Viraleze covid viral load claim?, page-13

No, we are definitely on topic.

Bid just posted ‘I think it is unfortunate some investors perpetuate the sentiment the trial was a failure’

So it’s only fair to counter with actual facts.
What Starpharma said:

’Viraleze™ reduced viral load in the full study population including all patient age groups (N=197),although the difference vs placebo was not statistically significant.’

Gee, who to believe? Some random on Hotcopper that has been wrong every step of the way? Or the CEO of Starpharma?

P.S. How’s that peer review coming along @Starlink that you insisted needed to be done prior to the Viraleze results to be released to market? Clueless.